Bellicum Pharmaceuticals Stock News

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

HOUSTON, March 05, 2020 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it.

Gainers Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....

Gainers Taubman Centers, Inc. (NYSE: TCO) shares jumped 53.2% to close at $53.12 on Monday. Simon Property Group, Inc. (NYSE: SPG) said Monday it plans to purchase an 80%...

NEW YORK (AP) — Changes announced in corporate dividends Feb. 3-Fev. 7. INCREASED DIVIDENDS Activision Blizzard .41 from .37 Aflac Inc .28 from .27 Arch Coal Inc Cl A .50 from .45 Avista Corp .405 f

Two publicly traded, clinical-stage pharmaceutical companies in Houston worked to better their financial runways Feb. 6 — one through a share purchase agreement, the other through a reverse stock s

The effective time of the reverse stock split will be 5 p.m. ET on February 5, 2020. The Company’s common stock will begin trading on a split-adjusted basis commencing upon market open on February

Bellicum Pharmaceuticals, Inc. (BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the Compensation Commi